Operating Income (Loss) in USD of IVERIC bio, Inc. from 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IVERIC bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2011 to Q1 2023.
  • IVERIC bio, Inc. Operating Income (Loss) for the quarter ending 31 Mar 2023 was -$73.8M, a 113% decline year-over-year.
  • IVERIC bio, Inc. Operating Income (Loss) for the twelve months ending 31 Mar 2023 was -$229M, a 86.9% decline year-over-year.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2022 was -$190M, a 65.5% decline from 2021.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2021 was -$115M, a 29.3% decline from 2020.
  • IVERIC bio, Inc. annual Operating Income (Loss) for 2020 was -$88.7M, a 44.8% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IVERIC bio, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$229M -$73.8M -$39.2M -113% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q4 2022 -$190M -$63M -$29.9M -90.3% 01 Oct 2022 31 Dec 2022 10-K 01 Mar 2023
Q3 2022 -$160M -$42.5M -$17.9M -72.9% 01 Jul 2022 30 Sep 2022 10-Q 04 Nov 2022
Q2 2022 -$142M -$49.8M -$19.5M -64.7% 01 Apr 2022 30 Jun 2022 10-Q 26 Jul 2022
Q1 2022 -$123M -$34.7M -$7.8M -29% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 -$115M -$33.1M -$7.6M -29.8% 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 -$107M -$24.6M +$901K +3.54% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022
Q2 2021 -$108M -$30.2M -$11.2M -58.9% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022
Q1 2021 -$96.9M -$26.9M -$8.12M -43.3% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q4 2020 -$88.7M -$25.5M -$7.65M -42.9% 01 Oct 2020 31 Dec 2020 10-K 04 Mar 2021
Q3 2020 -$81.1M -$25.5M -$10.4M -69.3% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 -$70.7M -$19M -$3.8M -25% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$66.9M -$18.7M -$5.58M -42.4% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$61.3M -$17.8M +$3.95M +18.1% 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2021
Q3 2019 -$65.2M -$15.1M +$318K +2.07% 01 Jul 2019 30 Sep 2019 10-K 04 Mar 2021
Q2 2019 -$65.5M -$15.2M -$359K -2.42% 01 Apr 2019 30 Jun 2019 10-K 04 Mar 2021
Q1 2019 -$65.2M -$13.2M +$165K +1.24% 01 Jan 2019 31 Mar 2019 10-K 04 Mar 2021
Q4 2018 -$65.3M -$21.8M -$6.94M -46.7% 01 Oct 2018 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 -$58.4M -$15.4M -$204M -108% 01 Jul 2018 30 Sep 2018 10-K 27 Feb 2020
Q2 2018 $146M -$14.8M +$7.7M +34.1% 01 Apr 2018 30 Jun 2018 10-K 27 Feb 2020
Q1 2018 $138M -$13.3M +$30.1M +69.3% 01 Jan 2018 31 Mar 2018 10-K 27 Feb 2020
Q4 2017 $108M -$14.9M +$52.2M +77.8% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 $55.8M $189M +$250M 01 Jul 2017 30 Sep 2017 10-K 28 Feb 2019
Q2 2017 -$194M -$22.5M +$8.01M +26.2% 01 Apr 2017 30 Jun 2017 10-K 28 Feb 2019
Q1 2017 -$202M -$43.5M -$6.73M -18.3% 01 Jan 2017 31 Mar 2017 10-K 28 Feb 2019
Q4 2016 -$196M -$67.1M -$25.9M -62.8% 01 Oct 2016 31 Dec 2016 10-K 05 Mar 2018
Q3 2016 -$170M -$61.2M -$13.8M -29% 01 Jul 2016 30 Sep 2016 10-K 05 Mar 2018
Q2 2016 -$156M -$30.6M +$11.9M +28% 01 Apr 2016 30 Jun 2016 10-K 05 Mar 2018
Q1 2016 -$168M -$36.7M -$44.3M -588% 01 Jan 2016 31 Mar 2016 10-K 05 Mar 2018
Q4 2015 -$124M -$41.2M -$10M -32.2% 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 -$113M -$47.4M -$61.1M -447% 01 Jul 2015 30 Sep 2015 10-K 28 Feb 2017
Q2 2015 -$52.4M -$42.4M -$144K -0.34% 01 Apr 2015 30 Jun 2015 10-K 28 Feb 2017
Q1 2015 -$52.3M $7.54M +$28.3M 01 Jan 2015 31 Mar 2015 10-K 28 Feb 2017
Q4 2014 -$80.5M -$31.2M -$10.7M -52.5% 01 Oct 2014 31 Dec 2014 10-K 26 Feb 2016
Q3 2014 -$69.8M $13.7M +$28.9M 01 Jul 2014 30 Sep 2014 10-K 26 Feb 2016
Q2 2014 -$98.7M -$42.3M -$34.7M -457% 01 Apr 2014 30 Jun 2014 10-K 26 Feb 2016
Q1 2014 -$64M -$20.7M -$16.6M -402% 01 Jan 2014 31 Mar 2014 10-K 26 Feb 2016
Q4 2013 -$47.4M -$20.4M -$16.9M -477% 01 Oct 2013 31 Dec 2013 10-K/A 28 Jul 2015
Q3 2013 -$30.5M -$15.3M -$11.4M -296% 01 Jul 2013 30 Sep 2013 10-K/A 28 Jul 2015
Q2 2013 -$19.1M -$7.59M -$4.31M -132% 01 Apr 2013 30 Jun 2013 10-K/A 28 Jul 2015
Q1 2013 -$14.8M -$4.13M -$1.12M -37.2% 01 Jan 2013 31 Mar 2013 10-K/A 28 Jul 2015
Q4 2012 -$13.7M -$3.55M 01 Oct 2012 30 Dec 2012 10-K 11 Mar 2014
Q3 2012 -$3.85M 01 Jul 2012 30 Sep 2012 10-K 11 Mar 2014
Q2 2012 -$3.27M 01 Apr 2012 30 Jun 2012 10-K 11 Mar 2014
Q1 2012 -$3.01M 01 Jan 2012 31 Mar 2012 10-K 11 Mar 2014

IVERIC bio, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$190M -$75.1M -65.5% 01 Jan 2022 31 Dec 2022 10-K 01 Mar 2023
2021 -$115M -$26M -29.3% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023
2020 -$88.7M -$27.5M -44.8% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 -$61.3M +$4.08M +6.24% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 -$65.3M -$173M -161% 01 Jan 2018 31 Dec 2018 10-K 04 Mar 2021
2017 $108M +$304M 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 -$196M -$72M -58.3% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 -$124M -$43M -53.4% 01 Jan 2015 31 Dec 2015 10-K 05 Mar 2018
2014 -$80.5M -$33.1M -69.8% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 -$47.4M -$33.7M -247% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016
2012 -$13.7M +$5.95M +30.3% 01 Jan 2012 31 Dec 2012 10-K/A 28 Jul 2015
2011 -$19.6M 01 Jan 2011 31 Dec 2011 10-K 11 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.